Seeking Alpha

AstraZeneca (AZN) says it received a favorable ruling from the U.S. District Court in New Jersey...

AstraZeneca (AZN) says it received a favorable ruling from the U.S. District Court in New Jersey that the formulation patent for its anti-psychotic drug Seroquel XR was valid. Torrent Pharmaceuticals and Mylan (MYL) were among those named that the court said had infringed the patent.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector